MULTI-LAYER OSTEOINDUCTIVE, OSTEOGENIC, AND OSTEOCONDUCTIVE CARRIER

Abstract

A method of making a multi-layer osteogenic carrier device for use in a vertebral column of a patient, comprising producing an elongated tubular structure, the elongated tubular structure comprising a closed end and an open end, wherein the open end is adapted for introducing an osteoinductive, osteogenic, and/or osteoconductive substance; cutting the elongated tubular structure to a certain length; introducing the osteoinductive, osteogenic, and/or osteoconductive substance into the open end of the elongated tubular structure; and closing the open end of the elongated tubular structure to form the multi-layer osteogenic carrier device.

Claims

1. A method of making a multi-layer osteogenic carrier device for use in a vertebral column of a patient, comprising: producing an elongated tubular structure, the elongated tubular structure comprising a closed end and an open end, wherein the open end is adapted for introducing an osteoinductive, osteogenic, and/or osteoconductive substance; cutting the elongated tubular structure to a certain length; introducing the osteoinductive, osteogenic, and/or osteoconductive substance into the open end of the elongated tubular structure; and closing the open end of the elongated tubular structure to form the multi-layer osteogenic carrier device.

2. The method of claim 1, wherein a porous substance is introduced into the elongated tubular structure along with the osteoinductive, osteogenic, and/or osteoconductive substance.

3. The method of claim 1, wherein the elongated tubular structure is produced in a predetermined length and/or size and/or thickness.

4. The method of claim 1, wherein the step of closing the open end of the elongated tubular structure comprises sewing, clipping, and/or sealing.

5. The method of claim 3, wherein the predetermined length and/or diameter of the elongated tubular structure is determined by the introduced substance.

6. The method of claim 1, wherein the multi-layer osteogenic carrier device further comprises at least one rod, at least one rod clip, and/or at least one fastener.

7. The method of claim 1, further comprising freezing or treating the multi-layer osteogenic carrier device.

8. The method of claim 7, wherein in use, the multi-layer osteogenic carrier device is produced in a predetermined length and/or diameter and/or thickness and multiple multi-layer osteogenic carrier devices are combined for use in the patient's vertebral column.

9. The method of claim 7, wherein in use, the multi-layer osteogenic carrier device is produced in a predetermined length and/or diameter and is cut for use in the patient's vertebral column.

10. The method of claim 1, wherein the elongated tubular material is adherent to bone and/or tissue.

11. The method of claim 1, wherein a support layer is applied to the exterior of the multi-layer osteogenic device.

12. A method of making a multi-layer osteogenic carrier device for use in a vertebral column of a patient, comprising: producing an elongated tubular structure, the elongated tubular structure comprising two closed ends and a port or opening, wherein the port or opening is adapted for introducing an osteoinductive, osteogenic, and/or osteoconductive substance; introducing the osteoinductive, osteogenic, and/or osteoconductive substance into the port or opening of the elongated tubular structure; and closing the port or opening of the elongated tubular structure to form the multi-layer osteogenic carrier device.

13. The method of claim 12, wherein a porous substance is introduced into the elongated tubular structure along with the osteoinductive, osteogenic, and/or osteoconductive substance.

14. The method of claim 12, wherein the elongated tubular structure is produced in a predetermined length and/or size and/or thickness.

15. The method of claim 12, wherein the step of closing the port or opening of the elongated tubular structure comprises sewing and/or sealing.

16. The method of claim 12, wherein the multi-layer osteogenic carrier device further comprises at least one rod, at least one rod clip, and/or at least one fastener.

17. The method of claim 12, further comprising freezing or treating the multi-layer osteogenic carrier device.

18. The method of claim 17, wherein in use, the multi-layer osteogenic carrier device is produced in a predetermined length and/or diameter and/or thickness and multiple multi-layer osteogenic carrier devices are combined for use in the patient's vertebral column.

19. The method of claim 12, wherein the elongated tubular material is adherent to bone and/or tissue.

20. The method of claim 12, wherein a support layer is applied to the exterior of the multi-layer osteogenic device.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0032] FIG. 1a illustrates an axial cross-sectional view of an exemplary embodiment of a carrier.

[0033] FIG. 1b illustrates a cross-sectional view of an alternative embodiment of a carrier.

[0034] FIG. 1c illustrates a longitudinal cross-sectional view of an exemplary embodiment of a carrier.

[0035] FIG. 2a illustrates an axial cross-sectional view of an exemplary embodiment of an empty/unpacked carrier.

[0036] FIG. 2b illustrates an axial cross-sectional view of an exemplary embodiment of a filled/packed carrier.

[0037] FIG. 3 illustrates a cross-sectional view of an exemplary embodiment of a rod clip.

[0038] FIG. 4a illustrates a cross-sectional view in the transverse plane of exemplary embodiments of a carrier and system for applying the carrier on the transverse process and lamina.

[0039] FIG. 4b illustrates a view in the coronal plane of a carrier and system for applying the carrier on the posterior surface.

[0040] FIG. 5 illustrates an exemplary embodiment of a carrier adapted for use in the cervical region of the vertebral column.

DETAILED DESCRIPTION

[0041] Referring now in detail to the Figures, wherein like reference numerals represent like parts throughout the several views, FIG. 1a illustrates an axial cross-sectional view of an exemplary embodiment of a carrier 100. The carrier 100 can comprise multiple layers serving distinct biologic functions and having different biologic properties. The layers can be composed of, able to stimulate, filled with, or impregnated with an osteogenic, osteoconductive, and/or osteoinductive substance and/or angiogenic factor.

[0042] As used herein, the term “osteogenic” refers to the development and formation of bone, which includes osteoinduction and osteoconduction. “Osteoinduction” or “osteoinductive” as used herein means facilitating, promoting, and/or inducing bone growth or formation. Stated another way, osteoinduction is the process of inducing osteogenesis. An osteoinductive substance or material as used herein refers to any substance, matrix, compound, material, or composition that facilitates, promotes, and/or induces bone growth or formation. Trinity™ and bone morphogenetic proteins are examples of osteoinductive substances. As used herein, the term “osteoconductive” or “osteoconduction” refers to any structure, material, device, matrix, or scaffold that facilitates the formation of bone structure. Trinity™ also has that property as do multiple other agents currently on the market such as Vitoss™. It is anticipated that newer agents will develop and the system described has the potential for use with multiple types of theoretical and actual biologics.

[0043] In an exemplary embodiment, the carrier 100 can be in the form of an elongate, tubular structure, which will be discussed further below. The carrier 100 can comprise a first layer 110, a second layer 120, and third layer 130. The second layer 120 can be disposed between the first layer 110 and the second layer 130.

[0044] The first layer 110 can be pliable and adherent to decorticated bone, and comprise the ventral or front side of the carrier 100. As such, the first layer 110 may be referred to as the adherent layer. When the carrier 100 is applied to a fusion site, the first layer 110 can be compressed onto the decorticated surface of the vertebrae where fusion is desired. The pliability and adherence of the first layer 110 enables the first layer 110 to substantially conform to the surface of the decorticated bone, maximizing the contact area between the bone and carrier 100, and prevent the carrier 100 drifting from the fusion site. The first layer 110 can have constant adherent properties, or alternatively, the first layer 110 can become adherent upon activation. The first layer 110 can be activated, for example and not limitation, by a fluid such as sterile saline, blood, or serum, or by another activating agent.

[0045] The first layer 110 can be constructed from an osteoinductive material optimally but alternative agents could conceivably be employed. In other contemplated embodiments, the first layer 110 can be able to stimulate or be impregnated or infused with an osteoinductive and/or angiogenic substance. The first layer 110 can be rapidly absorbed by the body. For example, it is preferable for the first layer 110 to be substantially absorbed relatively rapidly generally within 2-8 weeks although as biologics develop with shorter or longer durations, alternative absorptions rates are conceivable. For example only and not limitation, a material such as Infuse® containing Bone Morphogenetic Protein (rhBMP-2) exhibits substantially at least some of the properties preferred for the first layer 110. The first layer is preferably porous, absorbing blood or serum and allowing it to flow to the surface of the vertebrae to facilitate fusion.

[0046] The second layer 120 can compose the bulk of the carrier 100. The second layer 120 can define a hollow cavity 125 for receiving and holding an osteogenic, osteoconductive and/or osteoinductive substance and/or angiogenic factor. Accordingly, the second layer 120 may be referred to as the delivery layer. The second layer 120 can be thicker and be absorbed by the body slower than the first layer 110. For example only and not limitation, the second layer 120 can be preferably absorbed by the body in 26-52 weeks. The second layer can be porous, allowing blood or serum to seep into and intermix with the substance within the cavity 125, and for the substance to diffuse from the carrier 100 to the fusion site. The actual absorption time would be significantly dependent upon the in growth of the patient's own bone forming cells and vascularity. Once bone is formed by the patient the second layer is progressively absorbed and does not remain as an impediment to true bone formation.

[0047] The second layer 120 can be composed of an osteoconductive material or can have osteoconductive properties. The second layer 120 could additionally or alternatively be composed of an osteoinductive/osteogenic material or could have osteoinductive/osteogenic properties. The osteoconductive/osteoinductive properties of the second layer 120 combined with the osteoinductive properties of the substance disposed with the cavity 125 promote bone growth both within the second layer 120 itself and on the surface of the decorticated bone to facilitate fusion of vertebrae. Because the second layer is absorbent but is absorbed by the body slower than the first layer 110, it can be infiltrated by osteogenic cells from the body which would form the bone mass that would eventually extend to the decorticated surface facilitating fusion.

[0048] In alternative embodiments, the second layer 120 can be substantially uniform and not have a cavity 125 at its core. In such embodiments, an osteoinductive substance could be seeped or poured into the second layer 125, which would absorb and hold the substance like a sponge.

[0049] The third layer 130 can comprise the dorsal or back side of the carrier 100. The third layer 130 can in be communication with at least a portion of the second layer 120 (i.e., the delivery layer). As such, the third layer 130 can provide physical support to the delivery layer and may sometimes be referred to herein as a support layer. The third layer 130 can be rigid, substantially rigid, or may be moldable to a certain extent by the surgeon to form a variety of different shapes, contours, or configurations. For example, in some embodiments, the support layer is substantially rigid to achieve the desired effect. In other embodiments, the support layer is moldable to achieve the desired effect. The third layer 130 is preferably moldable by hand without special tools. The third layer 130 can be inherently or intrinsically moldable, or it can become moldable when activated. It may also be more rigid and in certain situations be able to achieve the same purpose. Thus, it is contemplated that moldability or rigidity of the support layer can be achieved by activating the support layer. For example and not limitation, the third layer 130 can be activated, by a fluid such as sterile saline, blood, or serum, or by another activating agent. Once the third layer 130 has been molded to a particular shape, it preferably retains that shape until it is remolded. The third layer could either be attached primarily to the other layers or could be a separate moldable layer that is cut to size, activated and then fits over the first two layers. In this last variation, the first and second layers could be of predetermined fixed lengths that are fitted to the defect and then held in place by the moldable third layer and the clips. When rigidity alone is sufficient, the clips may or may not be required to achieve the purpose of holding the first two layers in the optimal proximity.

[0050] The third layer 130 can hold the first layer 110 and second layer 120 in proximity to the decorticated bone and prevent them from becoming separated from the decorticated bone surface and lost within the surrounding muscle where they would be absorbed without any beneficial effect. The third layer 130 can be absorbed by the body at a substantially slower rate than the first layer 110 and second layer 120. For example only and not limitation, the third layer 130 can be preferably absorbed by the body in 26 weeks or longer. While the third layer 130 can be relatively dense and rigid compared to the first layer 110 and the second layer 120, it can allow bodily fluids to diffuse through it into the second layer 120 but preferably prevents the osteoinductive substance in the second layer from diffusing dorsally away from the fusion site where it would be absorbed by the body and effectively wasted.

[0051] The moldability and/or the rigid nature of the third layer 130 allow the carrier to conform to the surface contours of the bone at the fusion site and maximize the contact area between the carrier and fusion site. In embodiments having a moldable support layer, the surgeon can intraoperatively mold the third layer 130. The carrier 100 can be placed on the target fusion site, the third layer 130 can be pressed in the ventral direction so that the third layer 130 approximates and conforms to the shape of the fusion site while compressing the first layer 110 and second layer 120 against the decorticated bone.

[0052] The third layer 130 can interface with a spinal stabilization system to secure the carrier 100 to the fusion site. For example, one of more rod clips 300 (see FIG. 3) can be attached to rods of a spinal stabilization system, the rod clips 300 having an arm 340 that can press against the third layer 130 to secure the carrier 100 and prevent it from slipping or drifting out of place. Since the rod clips 300 can be attached anywhere on the rods, the carrier 100 can be optimally molded and placed to fit on a desired site on the vertebrae.

[0053] FIG. 1b illustrates a cross-sectional view of an alternative embodiment of a carrier 100. In accordance with this and similar exemplary embodiments, the carrier 100 may not comprise a separate first layer 110. The properties and functionality of the first layer 110 can be incorporated into the second layer 120 or omitted. For example, the ventral surface of the second layer 120 can be adherent or have an adherent substance or component integrated into it. In other contemplated embodiments, the first layer 110 can be integrally formed into the second layer 120, rather than comprising a separate and distinct layer. In further contemplated embodiments, the first layer 110 could be omitted entirely.

[0054] Embodiments of carrier 100 can have a variety of different constructs. In an exemplary embodiment, the carrier 100 can take the form of an elongate, tubular sleeve-like construct. FIG. 1c illustrates a longitudinal cross-sectional view of an exemplary embodiment of a carrier 100 taking the form of such a construct. The carrier 100 can have a closed end 102 and an open end 101 for receiving an osteogenic, osteoinductive and/or osteoconductive substance. The carrier 100 can be produced in a variety of predetermined lengths, and be cut at the open end 101 to a desired length. The configuration of the carrier 100 having an open end 101 is desirable when the osteogenic, osteoconductive/osteoinductive substance must be frozen because the carrier can be dry packaged and shipped/stored separate from the substance until the time of surgery. The carrier 100 can be filled with the osteoconductive/osteoinductive substance by inserting the substance through the open end 101 into the cavity 125 and sealing the open end 101 with sutures or another absorbable fastening means or method.

[0055] In alternative embodiments, the carrier 100 can be produced in predetermined sizes with the osteoconductive/osteoinductive substance already sealed within the cavity 125. In such embodiments, the carrier 100 would not have an open end and would not be cut to a desired size. It could be of variable sizes that are longitudinally placed and held in place by the clips 300. In this configuration, the third layer could be separate and could be molded over the construct formed by the first two layers and held in place by the clips 300. Alternatively, the carrier 100 could have a port or inlet for injecting/inserting an osteoconductive/osteoinductive substance into the cavity 225.

[0056] FIG. 2a illustrates an axial cross-sectional view of an exemplary embodiment of an empty/unpacked carrier 100. The carrier 100 can be substantially thinner when the cavity 225 is empty. It allows for easier transport and storage. FIG. 2b illustrates an axial cross-sectional view of an exemplary embodiment of a filled/packed carrier 100. The carrier 100 can expand as an osteoconductive/osteoinductive substance 250 is packed or inserted into the cavity 225.

[0057] FIG. 3 illustrates a cross-sectional view of an exemplary embodiment of a rod clip 300. The rod clip 300 can attach to a rod 305 of a spinal stabilization system to secure a carrier 100 onto the decorticated bone and prevent the carrier 100 from being lifted off the fusion site. The rod clip 300 can also facilitate the fusion process by compressing the carrier 100 against the fusion site.

[0058] In an exemplary embodiment, the rod clip 300 can comprise a first leg 310 and a second leg 320. The first leg 310 and second leg 320 can be curvilinear and substantially follow the curvature of the rod 305. As the rod clip 300 is be pressed against the rod 305, the first leg 310 and second legs 320 can snap onto the rod 305 and wrap around at least half of the circumference of the rod 305 to attached to rod clip 300 to the rod 305.

[0059] A stem 330 can connect the first leg 310 and second leg 320 to an arm 340. The arm 340 can extend from the stem 330 and first leg 310 and second leg 320. The arm 340 can include a bent tip 350. The arm 340 can engage or otherwise interface with the third layer 130 of the carrier 100. In particular, the carrier 100 can be compressed onto the fusion site by rotating the rod clip 300 around the rod 305 such that the arm 340 presses against the third layer 130. The bent tip 350 can provide press into the surface of the third layer 130 for additional grip or prevent the carrier 100 from sliding in the longitudinal direction along the length of the arm 340.

[0060] The rod clip 300 can include a fastener for fastening 360 the rod clip 300 to the rod 305. The legs 310 and 320 secure the rod clip 300 to the rod 305, but allow for a degree of rotation and sliding along the length of the rod 305. The fastening means 360 can secure the rod clip 300 to the rod 305 to limit the rotation and slippage of the rod clip 300. The fastening means 360 can be a mechanical fastener, such as a screw or bolt, or can be an adhesive, magnet, or other fixation element, mechanism or device.

[0061] FIG. 4a illustrates a cross-sectional view in the transverse plane of exemplary embodiments of a carrier 100 and system 400 for applying the carrier on the transverse process and lamina. The system 400 can comprise a spinal stabilization structure having pedicle screws 405 on adjacent vertebrae connected by a plurality of rods 305. A plurality of rod clips 300 can be attached to the rods 305 to keep a plurality of carriers 100 compressed on the decorticated bone of the target site. As used herein, the term “plurality” refers to more than one. FIG. 4b illustrates a view in the coronal plane of a carrier 100 and system 400 for applying the carrier 100 on the posterior surface of the vertebral column. In contemplated embodiments, the system 400 can comprise different spinal stabilization structures such as cages, structural allografts, interbody devices, and devices designed to be placed between and/or attached to the spinous processes, the vertebral bodies or onto and/or through the facets.

[0062] FIG. 5 illustrates an exemplary embodiment of a carrier 500 adapted for use in the cervical region of the vertebral column. The carrier 500 can have similar properties to the carrier 100, but is specifically adapted for insertion between vertebrae to facilitate fusion rather than for placement on the surface of vertebrae like carrier 100. The carrier 500 can be particularly adapted for insertion between the vertebrae of the cervical region of the vertebral column but in a larger form could also be used between the thoracic or lumbar bodies.

[0063] The carrier 500 can comprise a hollow cylindrical wall 520 defining an inner chamber 525. The wall 520 can be composed of a biocompatible material that is substantially rigid and capable of withstanding the axial forces in the cervical, thoracic or lumbar region of the vertebral column. In particular, when the carrier 500 is inserted between vertebrae in the cervical region, it will experience forces in downward and upward directions as the adjacent vertebrae compress the carrier 500. The carrier 500 preferably has sufficient structural integrity and rigidity to sustain these forces without buckling, cracking, or otherwise being structurally compromised. The wall 520 of the carrier 500 could be designed to be absorbed in a fashion which allows progressive load sharing as the fusion mass becomes more mature and more capable of withstanding axial loading.

[0064] The cylindrical wall 520 can be composed of material absorbable by the body. The wall 520 preferably is absorbed at a substantially slower rate than the other components of the carrier 500. Preferably, the wall 500 does not dissolve before the vertebrae are fused and are capable of sustaining axial loads present in the cervical spine unassisted. For example and not limitation, the wall 520 can be substantially absorbed by the body within 6-24 months. Within the cervical spine, settling is generally assumed to take place with six months although data suggests this process may continue over an even longer time period.

[0065] A core layer 510 can be disposed within the chamber 525. The core layer 510 can be substantially similar in functionality, properties, and attributes to the second layer 120 described above. The core layer 510 can define a cavity 530 for receiving an osteoinductive/osteoconductive substance. The cavity 530 can be pre-filed during the manufacturing process or can be filled prior to surgery by injecting the substance through a port 550 spanning the wall 520 and core layer 510.

[0066] Chamber plugs 540 can seal the top and bottom portions of the chamber 525. The plugs 540 can be substantially similar in functionality, properties, and attributes to the first layer 110 described above. The wall 520 and plugs 540 can substantially surround the core layer 510. Once inserted between vertebrae, the carrier 500 can promote fusion as the plugs 540 dissolve and bone growth occurs in and around the core layer 510. After a period of time, the entire chamber 525 may be filled with fused bone and the wall 520 will be absorbed by the body and also replaced with fused bone.

[0067] The various embodiments described above are intended to provide a carrier device, system for facilitating vertebral fusion, and a method of using and making said system and device. Consequently, the embodiments described above are merely exemplary and not limiting. In particular, the configurations, dimensions, orientation, inter-relationships, properties, attributes, and functionalities of elements described above can be modified from what has been recited and described without departing from the design of the invention.